@article{b8d059d3008744f387d9a58780f7fd69,
title = "Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients",
author = "Boons, {Christel C.L.M.} and Tromp, {Vashti N.M.F.} and Neppelenbroek, {Nienke J.M.} and Lonneke Timmers and {van Schoor}, {Natasja M.} and Swart, {Eleonora L.} and Hendrikse, {N. Harry} and Janssen, {Jeroen J.W.M.} and Hugtenburg, {Jacqueline G.}",
note = "Funding Information: The authors are responsible for the content of the article. J.J.W.M. Janssen is an advisory board member for Abbvie, Incyte, Jazz Pharmaceuticals, and Pfizer, and has received research support funding from Novartis and Bristol Myers Squibb and speaker{\textquoteright}s fees from Incyte and Pfizer. The other authors report no conflicts of interest. Funding Information: The data collection for this work was supported by an unrestricted grant by Novartis [CAMN107ENL04T]. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2019",
month = jun,
day = "3",
doi = "10.1080/0284186X.2019.1585944",
language = "English",
volume = "58",
pages = "891--896",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "6",
}